ARCHIVES

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

NIH Plans Meeting On Human Subjects Issues In Research

June 30, 1995

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89

January 13, 1989